Icahn School of Medicine at Mount Sinai, 1 Gustav L. Levy Place, New York, NY 10029-6574, USA.
Icahn School of Medicine at Mount Sinai, 1 Gustav L. Levy Place, New York, NY 10029-6574, USA.
Clin Liver Dis. 2019 May;23(2):309-329. doi: 10.1016/j.cld.2018.12.011. Epub 2019 Mar 5.
Liver disease in human immunodeficiency virus (HIV) remains a main cause of morbidity and mortality. Liver-related morbidity and mortality can be caused by multiple etiologic factors, including opportunistic infections, direct and indirect effects of antiretrovirals, direct and indirect effects of HIV, and viral hepatitides. These factors present with varied liver pathophysiologic mechanisms that lead to abnormalities in liver enzymes and synthetic function test, followed by distinct clinical presentations. This article elucidates the direct effects on HIV in the liver and explores the diagnostic and management challenges in patients with HIV in the era of highly active antiretroviral treatment.
在人类免疫缺陷病毒(HIV)患者中,肝脏疾病仍然是发病率和死亡率的主要原因。肝脏相关的发病率和死亡率可能由多种病因引起,包括机会性感染、抗逆转录病毒药物的直接和间接作用、HIV 的直接和间接作用以及病毒性肝炎。这些因素具有不同的肝脏病理生理机制,导致肝酶和合成功能试验异常,继而出现不同的临床表现。本文阐述了 HIV 对肝脏的直接影响,并探讨了在高效抗逆转录病毒治疗时代 HIV 患者的诊断和管理挑战。